GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JCL Bioassay Corporation (TSE:2190) » Definitions » Gross Margin %

JCL Bioassay (TSE:2190) Gross Margin % : 30.86% (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is JCL Bioassay Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. JCL Bioassay's Gross Profit for the three months ended in Sep. 2014 was 円189 Mil. JCL Bioassay's Revenue for the three months ended in Sep. 2014 was 円613 Mil. Therefore, JCL Bioassay's Gross Margin % for the quarter that ended in Sep. 2014 was 30.86%.


The historical rank and industry rank for JCL Bioassay's Gross Margin % or its related term are showing as below:

TSE:2190' s Gross Margin % Range Over the Past 10 Years
Min: 26.13   Med: 29.95   Max: 38.35
Current: 26.69


During the past 7 years, the highest Gross Margin % of JCL Bioassay was 38.35%. The lowest was 26.13%. And the median was 29.95%.

TSE:2190's Gross Margin % is not ranked
in the Biotechnology industry.
Industry Median: 60.88 vs TSE:2190: 26.69

JCL Bioassay had a gross margin of 30.86% for the quarter that ended in Sep. 2014 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for JCL Bioassay was 0.00% per year.


JCL Bioassay Gross Margin % Historical Data

The historical data trend for JCL Bioassay's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCL Bioassay Gross Margin % Chart

JCL Bioassay Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14
Gross Margin %
Get a 7-Day Free Trial 29.95 35.23 26.50 26.76 26.13

JCL Bioassay Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.75 29.27 29.66 11.33 30.86

Competitive Comparison of JCL Bioassay's Gross Margin %

For the Biotechnology subindustry, JCL Bioassay's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCL Bioassay's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JCL Bioassay's Gross Margin % distribution charts can be found below:

* The bar in red indicates where JCL Bioassay's Gross Margin % falls into.



JCL Bioassay Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

JCL Bioassay's Gross Margin for the fiscal year that ended in Mar. 2014 is calculated as

Gross Margin % (A: Mar. 2014 )=Gross Profit (A: Mar. 2014 ) / Revenue (A: Mar. 2014 )
=576.7 / 2207.383
=(Revenue - Cost of Goods Sold) / Revenue
=(2207.383 - 1630.683) / 2207.383
=26.13 %

JCL Bioassay's Gross Margin for the quarter that ended in Sep. 2014 is calculated as


Gross Margin % (Q: Sep. 2014 )=Gross Profit (Q: Sep. 2014 ) / Revenue (Q: Sep. 2014 )
=189.3 / 613.487
=(Revenue - Cost of Goods Sold) / Revenue
=(613.487 - 424.192) / 613.487
=30.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


JCL Bioassay  (TSE:2190) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

JCL Bioassay had a gross margin of 30.86% for the quarter that ended in Sep. 2014 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


JCL Bioassay Gross Margin % Related Terms

Thank you for viewing the detailed overview of JCL Bioassay's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


JCL Bioassay (TSE:2190) Business Description

Traded in Other Exchanges
N/A
Address
JCL Bioassay Corporation is engaged in providing clinical and non-clinical trial services for pharmaceutical companies.

JCL Bioassay (TSE:2190) Headlines

No Headlines